Oraliva, INC.
Last verified 2026-05-11. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.2Mattributed |
|---|---|
| Latest round | strategic, $1.2M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | Research Triangle Park, USA |
| Industry | unknown |
| Stage | series-b+ |
| Website | oraliva.com |
STTR PHASE II: PORTABLE SINGLE CELL CYTOLOGY AND PREDICTIVE ANALYSIS PLATFORM FOR THE EARLY DETECTION OF EPITHELIAL CANC
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | strategic | $1.2M | undisclosed |
Detected tech stack
Nginx 1.27.2, WordPress 6.9.4, Yoast SEO 27.2, Swiper, jQuery Migrate 3.4.1, Elementor 3.33.4, Endurance Page Cache, HubSpot, Contact Form 7 6.1.1, Creativ.eMail, Zepto, Bluehost
Provenance
| Fact | Status | Basis |
|---|---|---|
| Strategic, $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | oraliva.com, read 2026-05-11 |
| Description | self-reported | oraliva.com, read 2026-05-11 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.